Profile data is unavailable for this security.
About the company
GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.
- Revenue in USD (TTM)19.50bn
- Net income in USD1.57bn
- Incorporated2022
- Employees51.00k
- LocationGE Healthcare Technologies Inc500 West Monroe StreetCHICAGO 60661United StatesUSA
- Phone+1 (203) 360-4369
- Fax+1 (302) 655-5049
- Websitehttps://www.gehealthcare.com
More ▼
Mergers & acquisitions
| Acquired company | GEHC:NSQ since announced | Transaction value |
|---|---|---|
| MIM Software Inc | 3.72% | -- |
Data delayed at least 15 minutes, as of May 03 2024 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hologic Inc | 3.97bn | 515.10m | 17.82bn | 6.99k | 36.09 | 3.83 | 21.19 | 4.49 | 2.10 | 2.10 | 16.13 | 19.84 | 0.447 | 2.70 | 5.90 | 567,854.10 | 5.80 | 11.40 | 6.48 | 13.38 | 55.44 | 60.29 | 12.98 | 20.95 | 3.18 | -- | 0.3565 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Cooper Companies Inc | 3.67bn | 290.80m | 17.84bn | 15.00k | 90.70 | 2.32 | 26.80 | 4.87 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Baxter International Inc | 14.81bn | -76.00m | 18.80bn | 60.00k | -- | 2.23 | 15.75 | 1.27 | -0.1508 | 5.22 | 29.23 | 16.55 | 0.5238 | 3.43 | 5.48 | 246,883.30 | -0.244 | 0.1942 | -0.3054 | 0.2333 | 35.89 | 38.20 | -0.4658 | 0.3674 | 1.04 | 3.28 | 0.6197 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Steris PLC | 5.41bn | 566.84m | 20.38bn | 17.00k | 36.36 | 3.18 | 17.86 | 3.77 | 5.67 | 5.67 | 54.18 | 64.93 | 0.4864 | 3.94 | 6.05 | 318,081.40 | 5.11 | 3.99 | 5.54 | 4.37 | 43.60 | 43.41 | 10.50 | 7.90 | 1.49 | 6.42 | 0.3399 | 49.05 | 8.13 | 13.61 | -56.12 | -17.02 | 16.95 | 8.74 |
| Align Technology, Inc. | 3.92bn | 462.28m | 21.56bn | 21.61k | 47.20 | 5.74 | 46.49 | 5.51 | 6.07 | 6.07 | 51.44 | 49.96 | 0.6497 | 3.96 | 4.27 | 181,237.60 | 7.67 | 16.34 | 11.51 | 24.14 | 70.06 | 71.72 | 11.80 | 23.16 | 1.09 | -- | -- | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Zimmer Biomet Holdings Inc | 7.39bn | 1.02bn | 24.34bn | 18.00k | 24.23 | 1.95 | 12.31 | 3.29 | 4.89 | 4.89 | 35.26 | 60.70 | 0.3475 | 0.9195 | 5.24 | 410,794.40 | 4.82 | 2.21 | 5.49 | 2.52 | 71.82 | 71.25 | 13.86 | 7.28 | 0.7784 | 7.32 | 0.316 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 26.84bn | 10.60k | 48.58 | 10.03 | 38.69 | 9.16 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Resmed Inc | 4.58bn | 958.38m | 32.05bn | 10.14k | 33.58 | 6.92 | 28.15 | 6.99 | 6.50 | 6.50 | 31.07 | 31.52 | 0.6777 | 2.20 | 5.99 | 452,086.70 | 14.17 | 13.59 | 15.98 | 15.89 | 55.78 | 56.98 | 20.91 | 19.22 | 1.97 | 25.88 | 0.1786 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
| GE HealthCare Technologies Inc | 19.50bn | 1.57bn | 35.52bn | 51.00k | 22.66 | 4.79 | 15.97 | 1.82 | 3.43 | 3.43 | 42.54 | 16.24 | 0.6013 | 5.45 | 4.51 | 382,254.90 | 5.01 | -- | 6.86 | -- | 40.69 | -- | 8.33 | -- | 0.8335 | 5.27 | 0.5491 | -- | 6.60 | -- | -26.82 | -- | -- | -- |
| DexCom Inc | 3.80bn | 639.30m | 50.37bn | 9.60k | 83.48 | 22.33 | 60.23 | 13.25 | 1.52 | 1.52 | 8.99 | 5.67 | 0.6337 | 2.93 | 4.71 | 396,020.80 | 10.66 | 8.30 | 14.97 | 10.50 | 63.25 | 65.90 | 16.82 | 14.14 | 2.53 | -- | 0.526 | 0.00 | 24.49 | 28.56 | 58.70 | -- | 28.66 | -- |
| Edwards Lifesciences Corp | 6.14bn | 1.41bn | 51.26bn | 19.80k | 36.56 | 7.20 | 32.90 | 8.34 | 2.33 | 2.33 | 10.11 | 11.82 | 0.6682 | 1.35 | 8.00 | 310,272.70 | 15.34 | 16.63 | 17.58 | 19.12 | 76.63 | 76.71 | 22.95 | 24.84 | 2.67 | -- | 0.0767 | 0.00 | 11.56 | 10.03 | -7.85 | 13.70 | 1.96 | -- |
Data as of May 03 2024. Currency figures normalised to GE Healthcare Technologies Inc's reporting currency: US Dollar USD
41.58%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Capital Research & Management Co. (Global Investors)as of 31 Dec 2023 | 51.34m | 11.28% |
| The Vanguard Group, Inc.as of 29 Feb 2024 | 46.50m | 10.21% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 19.50m | 4.28% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 18.58m | 4.08% |
| Dodge & Coxas of 31 Dec 2023 | 16.98m | 3.73% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 11.56m | 2.54% |
| Geode Capital Management LLCas of 31 Dec 2023 | 7.73m | 1.70% |
| T. Rowe Price Investment Management, Inc.as of 31 Dec 2023 | 7.26m | 1.59% |
| Hotchkis & Wiley Capital Management LLCas of 31 Dec 2023 | 5.51m | 1.21% |
| Newport Trust Co.as of 31 Dec 2023 | 4.36m | 0.96% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
